BL-918 as a Novel Neuroprotective Agent Targeting SMP30 in Parkinson’s Disease: A Therapeutic Evaluation

Journal of Applied Pharmaceutical Science · Published 2026-07-19 · DOI 10.1177/22313354261464246

Free full text

Authors (4)

Hardi Makwana, Shasank Sekhar Swain, Biswaranjan Paital, Pranati Sar

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Makwana, H., Swain, S., Paital, B., et al. (2026). BL-918 as a Novel Neuroprotective Agent Targeting SMP30 in Parkinson’s Disease: A Therapeutic Evaluation. Journal of Applied Pharmaceutical Science. https://doi.org/10.1177/22313354261464246

Related articles